Ireland-based pharmaceutical company Allergan, through its subsidiaries Allergan Sales and Celestial Merger Sub, has agreed to acquire US-based development-stage biopharmaceutical company Repros Therapeutics.
Celestial Merger will purchase all outstanding shares of common stock of Repros Therapeutics for $0.67 a share, under the agreement.
The transaction was announced in December and will be closed in the first quarter of 2018.
Philippines-based life science equipment and services provider Philab Holdings plans to purchase a 67% share in pharmaceutical firm Sydenham Laboratories.
Philab will roll out a precision medicine programme post acquisition, which will boost the synergies of the two companies in the healthcare sector.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData